Engineering of chimeric enzymes with expanded tolerance to ionic strength.

Antimicrobial resistance poses a significant global threat, reaching dangerously high levels as reported by the World Health Organization. The emergence and rapid spread of new resistance mechanisms, coupled with the absence of effective treatments in recent decades, have led to thousands of deaths annually from infections caused by drug-resistant microorganisms. Consequently, there is an urgent need for the development of new compounds capable of combating antibiotic-resistant bacteria.

One fold, many functions-M23 family of peptidoglycan hydrolases.

Bacterial cell walls are the guards of cell integrity. They are composed of peptidoglycan that provides rigidity to sustain internal turgor and ensures isolation from the external environment. In addition, they harbor the enzymatic machinery to secure cell wall modulations needed throughout the bacterial lifespan.

Structural Characterization of EnpA D,L-Endopeptidase from Prophage Provides Insights into Substrate Specificity of M23 Peptidases.

The best-characterized members of the M23 family are glycyl-glycine hydrolases, such as lysostaphin (Lss) from or LytM from . Recently, enzymes with broad specificities were reported, such as EnpA from , that cleaves D,L peptide bond between the stem peptide and a cross-bridge. Previously, the activity of EnpA was demonstrated only on isolated peptidoglycan fragments.

Structural bases of peptidoglycan recognition by lysostaphin SH3b domain.

Staphylococcus simulans lysostaphin cleaves pentaglycine cross-bridges between stem peptides in the peptidoglycan of susceptible staphylococci, including S. aureus. This enzyme consists of an N-terminal catalytic domain and a cell wall binding domain (SH3b), which anchors the protein to peptidoglycan.